IKAR

Pharmaceutical Manufacturing The Significant Needs of Critically Ill Patients. the Company’s Lead Product Is Inomax® (Nitric Oxide) for Inhalation 98 employees

Employees: 98
Contacts: 4
Emails: 4

ikaria.com LinkedIn Crunchbase

IKAR Overview

Headquarters: The Significant Needs of Critically Ill Patients. the Company’s Lead Product Is Inomax® (Nitric Oxide) for Inhalation
Phone Number: Available in AeroLeads
Website: ikaria.com
Industry: Pharmaceutical Manufacturing
Employees: 98
Founded: 2007
Funding: 54.9M
Company Email: Available in AeroLeads
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

Hypoxic Respiratoty Failure Cardiac Remodeling post AMI (prevent CHF) Hepato-Renal Syndrome Pulmonary Arterial Hypertension (PAH) Pulmonary Hypertension Secondary to COPD

About IKAR

Ikaria, Inc. is a critical care company focused on developing and commercializing innovative therapies (drugs and devices) designed to address the significant needs of critically ill patients. The company’s lead product is INOMAX® (nitric oxide) for inhalation, the only FDA-approved drug for the treatment of hypoxic respiratory failure associated with pulmonary hypertension in term and near-term infants. It is offered through the INOMAX therapy package, an all-inclusive offering of drug product, drug-delivery system, on-site training and 24/7/365 technical assistance and support. The INOMAX therapy package is marketed in the USA, Puerto Rico, Canada, Australia, Mexico and Japan

IKAR Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage

IKAR Org Chart

Sample employees and titles

Name	Title	Location	Contact
Stephanie Krishnan		Singapore	Email
Leon Andrea	Office Manager at Ikaros Fly Aps	Copenhagen, Capital Region of Denmark, Denmark	Email
Alim Yıldırım		Istanbul, Türkiye, Turkey	Email
Karen Motus		Diamond Bar, California, United States	Email